Speaker: Marianne Fillion Head of Precision Medicine and Diagnostics

Convenor: Hilary Worton, VP Client Engagement, APLUSA

Aims of Webinar

• Leveraging PMR for Diagnostic Strategy
  • For diagnostics and precision medicine assets.
• PMR can be valuable to you and your team throughout the product lifecycle, but here are some key “moments”
• What does it provide to your Dx and CDx team?
  • Answers, Warnings, Guidance, Solutions, Strategies.
• Case study: Business Impact
  • Utilisation of a rare disease panel amongst GPs in Europe.
• Maximizing PMR Value
  • Challenges and hurdles to diagnostic market research, and how to minimise them.
  • Strategies for maximising ROI of your research project.
  • How do you know your research is valuable? DNA acrostic.
• Live Q&A

Key Takeaways:

• Market research is often underutilised in diagnostic development and in precision medicine.
• It is a valuable tool to provide insight and directions into product development, to forecast drivers and barriers and identify solutions to mitigate hurdles throughout the product lifecycle.
• It is essential to ensuring access to testing to all patients who are candidate for targeted therapies, as it provides critical information on patient leakage due to testing.

Speaker: Marianne Fillion Head of Precision Medicine and Diagnostics

• Marianne joined Purdie Pascoe in 2021, with more than 20 years’ experience in specialty pharmaceutical market research and strategy.
• Prior to joining PP, Marianne held the Head of Market Research and subsequently Head of Commercial Analytics and strategy positions at Diaceutics. 
• Marianne’s experience spans several complex therapeutic indications and includes all types of global market research studies. She has a specific and unique expertise in precision medicine, diagnostics and oncology market research, complemented by an MSc in Molecular Biology.